• MeSH
• Anti-Bacterial Agents MeSH
• Drug Resistance, Microbial MeSH
• Chloramphenicol MeSH
• Haemophilus influenzae drug effects   MeSH
• Microbial Sensitivity Tests MeSH
• In Vitro Techniques MeSH

• MeSH
• Anti-Infective Agents therapeutic use   MeSH
• Communicable Diseases drug therapy   MeSH
• Microbiological Techniques MeSH

• Conspectus
• Mikrobiologie
• NML Fields
• mikrobiologie, lékařská mikrobiologie
• NML Publication type
• elektronické časopisy

• MeSH
• Anti-Bacterial Agents MeSH
• Drug Resistance, Microbial MeSH
• Chloramphenicol MeSH
• Haemophilus influenzae drug effects   MeSH
• Microbial Sensitivity Tests MeSH
• In Vitro Techniques MeSH

• MeSH
• Anti-Infective Agents MeSH
• Minocycline analogs & derivatives   MeSH
• Penicillins pharmacology   pharmacokinetics   therapeutic use   MeSH
• Publication type
• Collected Work MeSH

• Conspectus
• Farmacie. Farmakologie
• NML Fields
• farmacie a farmakologie
• farmacie a farmakologie
• infekční lékařství

• MeSH
• Aeromonas hydrophila genetics   isolation & purification   classification   MeSH
• Anti-Bacterial Agents MeSH
• Drug Resistance, Bacterial MeSH
• beta-Lactam Resistance MeSH
• Phenotype MeSH
• Humans MeSH
• Check Tag
• Humans MeSH

• MeSH
• Drug Resistance, Microbial drug effects   MeSH
• Anti-Infective Agents classification   adverse effects   MeSH
• Risk Management MeSH

• Conspectus
• Farmacie. Farmakologie
• NML Fields
• farmacie a farmakologie
• farmakoterapie
• NML Publication type
• publikace WHO

• Keywords
• ústrojí močové - infekce mikrobiální - chemoterapie - sborníky prací,

• Conspectus
• Patologie. Klinická medicína
• NML Fields
• nefrologie
• mikrobiologie, lékařská mikrobiologie
• urologie

• MeSH
• Anti-Bacterial Agents * MeSH
• Drug Resistance, Microbial * MeSH
• Congresses as Topic MeSH

• MeSH
• Communicable Diseases MeSH

• Conspectus
• Farmacie. Farmakologie
• NML Fields
• farmacie a farmakologie
• infekční lékařství

With a growing health threat of bacterial resistance to antibiotics, the nanomaterials have been extensively studied as an alternative. It is assumed that antimicrobial nanomaterials can affect bacteria by several mechanisms simultaneously and thereby overcome antibiotic resistance. Another promising potential use is employing nanomaterials as nanocarriers for antibiotics in order to overcome bacterial defense mechanisms. The passive targeting of nanomaterials is the often used strategy for bacterial treatment, including intracellular infections of macrophages. Furthermore, the specific targeting enhances the efficacy of antimicrobials and reduces side effects. This review aims to discuss advantages, disadvantages, and challenges of nanomaterials in the context of the targeting strategies for antimicrobials as advanced tools for treatments of bacterial infections. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease.

• MeSH
• Anti-Infective Agents * MeSH
• Bacterial Infections drug therapy   MeSH
• Drug Resistance, Bacterial MeSH
• Humans MeSH
• Nanomedicine MeSH
• Nanostructures * MeSH
• Drug Discovery MeSH
• Check Tag
• Humans MeSH
• Publication type
• Journal Article MeSH
• Research Support, Non-U.S. Gov't MeSH
• Review MeSH